http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180083941-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-28122 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-576 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 |
filingDate | 2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd74909bcc582a2e33a401c3cfa02b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02cf32d04a76b2577a5bb6217ffc979 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84b7482a6693a9a61bdfc267764dd57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3cc8dff9858a953f5de14ecf50b3f3c |
publicationDate | 2018-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20180083941-A |
titleOfInvention | Mutant HEV polypeptides and their uses for assaying anti-HEV antibodies |
abstract | The present invention provides a polynucleotide having at least the amino acid sequence of SEQ ID NO: 394 to 660 (wherein the three cysteines at positions 627, 630 and 638 are mutated) or the p-ORF2 protein of 660 amino acids, In the case of the -ORF2 protein, at least an amino acid sequence corresponding to amino acids 394 to 660 of the p-ORF2 protein of 660 amino acids, wherein 3 (corresponding to positions 627, 630 and 638 of the p-ORF2 protein of 660 amino acids 3 < / RTI > cysteine located at the < RTI ID = 0.0 > position < / RTI > of the p-ORF2 protein is mutated). The present invention also relates to a method for measuring the presence of a humoral response or titer of an indicated antibody to a p-ORF2 protein using these polypeptides and its use in connection with infection by hepatitis E virus. |
priorityDate | 2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 826.